.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Check market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Magnesium sulfate anhydrous; potassium sulfate; sodium sulfate - Generic Drug Details

« Back to Dashboard
Magnesium sulfate anhydrous; potassium sulfate; sodium sulfate is the generic ingredient in one branded drug marketed by Braintree Labs and is included in one NDA. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

This ingredient has seventeen patent family members in thirteen countries.

There are one hundred and twenty-eight drug master file entries for magnesium sulfate anhydrous; potassium sulfate; sodium sulfate. One supplier is listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: magnesium sulfate anhydrous; potassium sulfate; sodium sulfate

Tradenames:1
Patents:1
Applicants:1
NDAs:1
Drug Master File Entries: see list128
Suppliers / Packagers: see list1
Clinical Trials: see list1,409
Formulation / Manufacturing:see details
Drug Prices:see low prices

Tentative approvals for MAGNESIUM SULFATE ANHYDROUS; POTASSIUM SULFATE; SODIUM SULFATE

Applicant Application No. Form Dosage
<disabled><disabled>SOLUTION;ORAL1.6GM/BOT; 3.13GM/BOT; 17.5GM/BOT
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Braintree Labs
SUPREP BOWEL PREP KIT
magnesium sulfate anhydrous; potassium sulfate; sodium sulfate
SOLUTION;ORAL022372-001Aug 5, 2010RXYes6,946,149► subscribeY ► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: magnesium sulfate anhydrous; potassium sulfate; sodium sulfate

Country Document Number Estimated Expiration
Cyprus1110011► subscribe
Denmark2233147► subscribe
Spain2340920► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: MAGNESIUM SULFATE ANHYDROUS; POTASSIUM SULFATE; SODIUM SULFATE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
00615Netherlands► subscribePRODUCT NAME: NATRIUMSULFAAT, MAGNESIUMSULFAAT EN KALIUMSULFAAT; NAT. REGISTRATION NO/DATE: RVG 110863 20130417; FIRST REGISTRATION: BE 434323 20130220
0483Netherlands► subscribePRODUCT NAME: NAXOPREN EN ESOMEPRAZOL ALS MAGNESIUMTRIHYDRAAT; NATIONAL REGISTRATION NO/DATE: RVG 106235 20101118; FIRST REGISTRATION: GB PL 17091/0263 - 0001 20101105
C/GB01/006United Kingdom► subscribePRODUCT NAME: ESOMEPRAZOLE AS MAGNESIUM TRIHYDRATE; REGISTERED: SE 15945 20000310; SE 15946 20000310; UK PL 17901/0068-0069 20000727
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc